Genprex, Inc. Files 8-K on Delisting Notice
Ticker: GNPX · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1595248
Sentiment: bearish
Topics: delisting, listing-standards, financials
Related Tickers: GNPX
TL;DR
Genprex 8-K: Delisting notice filed. Uh oh.
AI Summary
Genprex, Inc. filed an 8-K on June 6, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Austin, TX.
Why It Matters
This filing indicates potential issues with Genprex, Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can lead to severe stock price declines and reduced liquidity.
Key Numbers
- 001-38244 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- June 6, 2025 (date) — Date of earliest event reported
- Austin, TX (location) — Principal executive offices location
- 001-38244 (other) — Commission File Number
FAQ
What specific listing rule or standard did Genprex, Inc. fail to satisfy?
The filing does not specify the exact rule or standard that Genprex, Inc. failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard was issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 6, 2025.
Where are Genprex, Inc.'s principal executive offices located?
Genprex, Inc.'s principal executive offices are located at 3300 Bee Cave Road, #650-227, Austin, TX 78746.
What is the Commission File Number for Genprex, Inc.?
The Commission File Number for Genprex, Inc. is 001-38244.
What are the two main items reported in this 8-K filing?
This 8-K filing reports a notice of delisting or failure to satisfy a continued listing rule or standard, and also includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Genprex, Inc. (GNPX).